Filed Pursuant to Rule 433
Issuer Free Writing Prospectus dated January 3, 2023
Registration Statement No. 333-261416
Registration Statement No. 333-261416-01
Enterprise Products Operating LLC
Enterprise Products Partners L.P.
PRICING TERM SHEET
The information in this pricing supplement supplements the preliminary prospectus supplement, dated January 3, 2023 (the Preliminary Prospectus Supplement) and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement.
|Issuer:||Enterprise Products Operating LLC|
|Guarantee:||Unconditionally guaranteed by Enterprise Products Partners L.P.|
Baa1 by Moodys Investors Service, Inc.
BBB+ by S&P Global Ratings
BBB+ by Fitch Ratings Inc.
|Note Type:||Senior Unsecured Notes|
|Legal Format:||SEC Registered|
|Trade Date:||January 3, 2023|
|Expected Settlement Date**:||January 10, 2023 (T+5)|
|Net Proceeds (after underwriting discounts and $3.8 million of other offering expenses):||$1,734,270,900|
Senior Notes Due 2026
|Maturity Date:||January 10, 2026||January 31, 2033|
|Benchmark Treasury:||4.000% due December 15, 2025||4.125% due November 15, 2032|
|Benchmark Treasury Yield:||4.189%||3.775%|
|Spread to Benchmark:||+ 90 bps||+ 160 bps|
|Yield to Maturity:||5.089%||5.375%|
|Price to Public:||99.893% of the principal amount||99.803% of the principal amount|
|Make-Whole Call:||T + 15 bps||T + 25 bps|
|Call at Par:||Not Applicable||On or after October 31, 2032|
|Interest Payment Dates:||January 10 and July 10, beginning July 10, 2023||January 31 and July 31, beginning July 31, 2023|
|CUSIP / ISIN:||29379VCC5 / US29379VCC54||29379VCD3 / US29379VCD38|
|Joint Book-Running Managers:|| |
J.P. Morgan Securities LLC
BofA Securities, Inc.
Morgan Stanley & Co. LLC
RBC Capital Markets, LLC
Barclays Capital Inc.
BMO Capital Markets Corp.
Mizuho Securities USA LLC
SMBC Nikko Securities America, Inc.
Truist Securities, Inc.
Wells Fargo Securities, LLC
BBVA Securities Inc.
Citigroup Global Markets Inc.
Credit Agricole Securities (USA) Inc.
Credit Suisse Securities (USA) LLC
Deutsche Bank Securities Inc.
MUFG Securities Americas Inc.
PNC Capital Markets LLC
Scotia Capital (USA) Inc.
SG Americas Securities, LLC
TD Securities (USA) LLC
U.S. Bancorp Investments, Inc.
Note: A securities rating is not a recommendation to buy, sell or hold securities and is subject to revision or withdrawal at any time.
We expect delivery of the 2026 Notes and the 2033 Notes will be made against payment therefor on or about January 10, 2023, which is the fifth business day following the date of pricing of such notes (such settlement being referred to as T+5). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the 2026 Notes and/or the 2033 Notes prior to the second trading day prior to the closing of this offering will be required, by virtue of the fact that such notes initially will settle in T+5, to specify an alternate settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisers.
The Issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the SEC) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and any other documents the Issuer has filed with
the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SECs website at http://www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting J.P. Morgan Securities LLC at (212) 834-4533, BofA Securities, Inc. at (800) 294-1322, Morgan Stanley & Co. LLC at (866) 718-1649 or RBC Capital Markets, LLC at (866) 375-6829.
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.